Corrigendum to “Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial” [Eur J Cancer. 227 (2025) 115674] (European Journal of Cancer (2025) 227, (S0959804925004563), (10.1016/j.ejca.2025.115674))

Demidov, L., Samoylenko, I., Kharkevich, G., Orlova, K., Moiseenko, V., Utyashev, I., Stroyakovskiy, D., Kozlov, V., Zimina, A., Mochalova, A., Demidova, S., Lyadova, M., Kutkovich, A., Skopin, P., Kovalenko, N., Safina, S., Volkov, V., Semiletova, Y., Vaschenko, V., Kislov, N. & 30 others, Poltoratskiy, A., Shumskaya, I., Kolomiets, S., Sobolev, A., Belogortsev, I., Odintsova, S., Rastogi, S., Andabekov, T., Penkov, K., Semenova, A., Obukhov, A., Belyakovsky, V., Yurchenkov, A., Gladkov, O., Neve, R., Falaleeva, N., Poddubskaya, E., Vaibhav, A., Kirtbaya, D., Chapko, Y., Smagina, M., Fadeeva, N., Sorokina, I., Mikhailova, E., Lin’kova, Y., Zinkina-Orikhan, A., Lutskii, A., Gabidullin, R., Rzaev, R. & Kryukov, F., 30 Aug 2025, In: European Journal of Cancer. 228

Research output: Contribution to journal › Comment/debate › peer-review

现阶段俄罗斯与欧盟经贸关系 的问题和前景 阿列克桑德拉·莫恰洛娃 谢尔盖·苏特林

Сутырин, С. Ф. & Мочалова, А. И., Feb 2025, In: Russian Studies. 251, 1, p. 145-164

Research output: Contribution to journal › Article › peer-review

Maintenance avelumab in metastatic urothelial carcinoma: do tumour site and previous surgery matter?

Zukov, R., Gridneva, Y., Anzhiganova, Y., Sultanbaev, A., Gluzman, M., Mochalova, A., Shkurat, A., Israelyan, E., Parsadanova, E., Murzina, Y., Ivanov, A., Kalpinskiy, A., Stativko, O., Petkau, V., Karabina, E., Koln, A., Tovbik, N., Safina, S., Turganova, M., Kopyltsov, E. & 9 others, Bragina, V., Novikova, O., Lebedinets, A., Vodolazskiy, V., Rumyantsev, A., Pokataev, I., Orlova, R., Volkova, M. & Tsimafeyeu, I., 2025, In: BJU International. 137, 1, p. 72-75

Research output: Contribution to journal › Article › peer-review